CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Oxidative-stress-induced telomere instability drives T cell dysfunction in cancer.
Oxidative-stress-induced telomere instability drives T cell dysfunction in cancer.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肿瘤微环境(TME)施加的免疫和代谢压力足以使免疫细胞分化偏离至功能失调状态。源自线粒体的氧化应激可诱导DNA损伤,尤其是端粒。在此,我们表明癌症中功能失调的T细胞并不具有提示复制性衰老的短端粒,而是具有受损的端粒,我们假设这源于氧化应激。使用光敏剂通过化学-光遗传学诱导高度局限的线粒体或端粒活性氧(ROS),导致端粒处DNA损伤的积累,驱动端粒脆性。端粒损伤足以驱动T细胞进入功能失调状态,表现为细胞因子产生能力下降。将ROS清除剂GPX1直接定位到端粒可减少肿瘤中的端粒脆性并改善治疗性T细胞的功能。通过表达靶向端粒的抗氧化剂来保护端粒,可能保留TME中T细胞的功能并驱动对细胞疗法更优的应答。
The tumor microenvironment (TME) imposes immunologic and metabolic stresses sufficient to deviate immune cell differentiation into dysfunctional states. Oxidative stress originating in the mitochondria can induce DNA damage, most notably telomeres.
Here, we show that dysfunctional T cells in cancer did not harbor short telomeres indicative of replicative senescence but rather harbored damaged telomeres, which we hypothesized arose from oxidative stress. Chemo-optogenetic induction of highly localized mitochondrial or telomeric reactive oxygen species (ROS) using a photosensitizer caused the accumulation of DNA damage at telomeres, driving telomere fragility.
Telomeric damage was sufficient to drive a dysfunctional state in T cells, showing a diminished capability for cytokine production. Localizing the ROS scavenger GPX1 directly to telomeres reduced telomere fragility in tumors and improved the function of therapeutic T cells. Protecting telomeres through expression of a telomere-targeted antioxidant may preserve T cell function in the TME and drive superior responses to cell therapies.
在 PubMed 查看 → 出版商原文(DOI) 全文 PDF(PMC)· 可下载 治疗专题与资料阅读指南 资料来源与翻译说明 报告译文或资料问题 →
MEMBER ACCOUNT
登录成功会直接打开下一页。